ArcBest director granted 1,350 ARCB shares
ArcBest Corp. director Chris T. Sultemeier received a stock grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ArcBest Corp. director Chris T. Sultemeier received a stock grant. On May 5, 2026, he was awarded 1,350 shares of ArcBest common stock at a stated price of $0.00 per share, indicating compensation rather than a market purchase.
Following this award, Sultemeier directly holds 3,800 shares of ArcBest common stock. The filing does not show any sales or option exercises, only this routine director-level equity grant that increases his direct ownership stake.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.01 per share | 1,350 | $0.00 | $0.00 |
Key Figures
Key Terms
Form 4 regulatory
Grant, award, or other acquisition financial
transaction code A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ARCB director Chris T. Sultemeier report?
Was the ARCB insider transaction a stock purchase or a grant?
What does transaction code “A” mean in the ARCB Form 4 filing?
Does the ARCB Form 4 show any stock sales by Chris T. Sultemeier?
AI-generated analysis. How Rhea-AI works. Not financial advice.